β2-Agonists prevent Th1 development by selective inhibition of interleukin 12 - Panina-Bordignon,P.; Mazzeo,D.; Lucia,P.D.; D'Ambrosio,D.; Lang,R.; Fabbri,L.; Self,C.; Sinigaglia,F. (J Clin Invest, 1997)